Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 x 2 factorial phase 3trial

This article has no abstract
Epistemonikos ID: 2acb7e5dacd0420164be949d7c080e546e791164
First added on: Jan 24, 2026